Knowledge Center
Article / Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Source:
Pharma's Almanac, Q4 2016, 23 October 2016
There is growing demand for聽dry-powder inhalation formulations聽of drugs to treat both respiratory and systemic diseases. Composite particle technology is allowing the development of more efficient formulations, even for challenging molecules.聽Spray drying聽is an聽 enabling technology for composite particle preparation. Formulators must be aware, however, of the tradeoffs between properties that improve aerodynamic performance in the lung but negatively impact聽 process yields or throughputs.
Related links
Also in the Knowledge Center
Scientific Article
/ Apr 16, 2020
Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites
Read more
Scientific Article
/ Jan 05, 2020
A multicentre, randomized, double鈥恗asked, parallel group, vehicle鈥恈ontrolled phase IIb study
Read more
Scientific Article